Effectiveness of 3TC in HIV clinical trials may be due in part to the M184V substitution in 3TC-resistant HIV-1 reverse transcriptase.

Source:http://linkedlifedata.com/resource/pubmed/id/9030390

Download in:

View as

General Info

PMID
9030390